Larvol Delta - A-Study-to-Identify-an-Optimal-Dose-of-QCZ484-in-Mild-to-Moderate-Hypertensive-Patients

QCZ484 - Novartis

http://clinicaltrials.gov/ct2/show/NCT06857955

Jun 2, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next